As of 2026-05-21, the EV/EBITDA ratio of CTC Bio Inc (060590.KQ) is 7.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 060590.KQ's latest enterprise value is 116,614.50 mil KRW. 060590.KQ's TTM EBITDA according to its financial statements is 15,115.34 mil KRW. Dividing these 2 quantities gives us the above 060590.KQ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 10.5x | 10.0x |
| Forward P/E multiples | 8.3x - 11.9x | 11.0x |
| Fair Price | 1,863.67 - 5,450.94 | 3,996.36 |
| Upside | -50.1% - 45.9% | 7.0% |
| Date | EV/EBITDA |
| 2026-05-20 | 7.52 |
| 2026-05-19 | 7.71 |
| 2026-05-18 | 7.83 |
| 2026-05-15 | 7.97 |
| 2026-05-14 | 8.14 |
| 2026-05-13 | 7.93 |
| 2026-05-12 | 8.46 |
| 2026-05-11 | 7.44 |
| 2026-05-08 | 7.60 |
| 2026-05-07 | 7.62 |
| 2026-05-06 | 7.61 |
| 2026-05-04 | 7.91 |
| 2026-04-30 | 8.00 |
| 2026-04-29 | 7.99 |
| 2026-04-28 | 7.91 |
| 2026-04-27 | 7.95 |
| 2026-04-24 | 8.09 |
| 2026-04-23 | 7.97 |
| 2026-04-22 | 7.95 |
| 2026-04-21 | 8.07 |
| 2026-04-20 | 8.19 |
| 2026-04-17 | 8.39 |
| 2026-04-16 | 8.21 |
| 2026-04-15 | 7.98 |
| 2026-04-14 | 7.83 |
| 2026-04-13 | 7.70 |
| 2026-04-10 | 7.67 |
| 2026-04-09 | 7.56 |
| 2026-04-08 | 7.67 |
| 2026-04-07 | 7.53 |
| 2026-04-06 | 7.64 |
| 2026-04-03 | 7.77 |
| 2026-04-02 | 7.67 |
| 2026-04-01 | 7.97 |
| 2026-03-31 | 7.80 |
| 2026-03-30 | 7.90 |
| 2026-03-27 | 8.05 |
| 2026-03-26 | 8.04 |
| 2026-03-25 | 8.04 |
| 2026-03-24 | 7.99 |
| 2026-03-23 | 7.87 |
| 2026-03-20 | 8.11 |
| 2026-03-19 | 8.02 |
| 2026-03-18 | 8.11 |
| 2026-03-17 | 8.16 |
| 2026-03-16 | 8.17 |
| 2026-03-13 | 8.25 |
| 2026-03-12 | 8.09 |
| 2026-03-11 | 8.09 |
| 2026-03-10 | 8.15 |